Status:
COMPLETED
Detection of Asymptomatic Atrial Fibrillation in Persons of 65 Year of Age or Older
Lead Sponsor:
Diagram B.V.
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
65+ years
Brief Summary
Atrial fibrillation (AF) is the most common cardiac arrhythmia. Although the condition itself is not life-threatening, the complications result in increased morbidity and mortality. AF is often asympt...
Detailed Description
Study design: Prospective validation study.
Eligibility Criteria
Inclusion
- Age ≥65 years
- Is willing to give informed consent
Exclusion
- Known medical history with Atrial Fibrillation
- Not mental competent
Key Trial Info
Start Date :
July 2 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2021
Estimated Enrollment :
2168 Patients enrolled
Trial Details
Trial ID
NCT04375241
Start Date
July 2 2018
End Date
April 30 2021
Last Update
July 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Isala
Zwolle, Overijssel, Netherlands, 8025AB